Technical Analysis for AGN - Allergan, Inc.

Grade Last Price % Change Price Change
grade C 162.46 -1.10% -1.80
AGN closed down 1.1 percent on Wednesday, July 17, 2019, on 85 percent of normal volume.

Earnings due: Jul 24

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical AGN trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 25.38%
Multiple of Ten Bearish Other 25.38%
Overbought Stochastic Strength 25.38%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 24.20%
Stochastic Reached Overbought Strength 24.20%
Multiple of Ten Bullish Other 24.20%
Weak + Overbought Other 24.20%
Inside Day Range Contraction 24.20%
Overbought Stochastic Strength 24.20%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 24.19%

Older signals for AGN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and over-the-counter skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. It focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, urologists, and general practitioners. The company has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Medicine Medical Specialties Life Sciences Pharmaceutical Surgery Pharmaceutical Products Inflammation Infection Psoriasis Medical Devices Glaucoma Acne Allergy Medical Device Skin Care Products Ophthalmic Products Breast Implant Breast Implants Over The Counter Products Retinal Disease Allergan Bausch Health Food Stores
Is AGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 197.0
52 Week Low 114.27
Average Volume 4,615,083
200-Day Moving Average 150.416
50-Day Moving Average 141.8748
20-Day Moving Average 158.8425
10-Day Moving Average 166.002
Average True Range 3.6702
ADX 40.43
+DI 39.6612
-DI 21.3887
Chandelier Exit (Long, 3 ATRs ) 159.1794
Chandelier Exit (Short, 3 ATRs ) 125.2806
Upper Bollinger Band 188.0785
Lower Bollinger Band 129.6065
Percent B (%b) 0.56
BandWidth 36.811307
MACD Line 7.8538
MACD Signal Line 8.5487
MACD Histogram -0.6949
Fundamentals Value
Market Cap 54.31 Billion
Num Shares 334 Million
EPS 32.82
Price-to-Earnings (P/E) Ratio 4.95
Price-to-Sales 3.91
Price-to-Book 0.84
PEG Ratio 0.97
Dividend 2.80
Dividend Yield 1.72%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 166.05
Resistance 3 (R3) 166.44 165.65 165.45
Resistance 2 (R2) 165.65 164.73 165.45 165.25
Resistance 1 (R1) 164.05 164.17 163.66 163.66 165.05
Pivot Point 163.26 163.26 163.06 163.06 163.26
Support 1 (S1) 161.66 162.34 161.27 161.27 159.87
Support 2 (S2) 160.87 161.78 160.67 159.67
Support 3 (S3) 159.27 160.87 159.47
Support 4 (S4) 158.88